State of New Jersey Common Pension Fund D’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Other funds holding DNLI
State of New Jersey Common Pension Fund D's DNLI Position: Q2 2026 in Review
State of New Jersey Common Pension Fund D reduced its Denali Therapeutics (DNLI) stake by 8.2% in Q2 2026, selling an estimated $79.8K and leaving 43,587 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1487.
State of New Jersey Common Pension Fund D first reported a position in DNLI in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.69M in Q4 2020. 147 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.
- State of New Jersey Common Pension Fund D held 43,587 shares of Denali Therapeutics worth $1.12M as of Q2 2026.
- State of New Jersey Common Pension Fund D sold 3,884 Denali Therapeutics shares in Q2 2026, an estimated $79.8K.
- Denali Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1487 holding.
- State of New Jersey Common Pension Fund D first reported a position in Denali Therapeutics in Q2 2020 and has held it in 25 quarters since.
- State of New Jersey Common Pension Fund D's Denali Therapeutics position peaked at $4.69M in Q4 2020.
- 147 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.